CDB Leasing Announces 2021 Interim Results

indie 31 8 月

9 minutes

HONG KONG, Aug 30, 2021 - (ACN Newswire via SEAPRWire.com) - China Development Bank Financial Leasing Co., Ltd. ( "CDB Leasing" or "the Company"; stock code: 1606.HK) announces its interim results ended June 30, 2021 (the "Reporting Period").Results Highlight:For the six months ended June 30, 2021:-- Total lease financing to lessees amounted to RMB57.1 billion, representing an increase of 12% YOY; -- Net profit reached RMB1.8 billion, representing an increase of 46.2% YOY;-- Total revenue and other income was RMB10.4 billion, representing an increase of 8.6% YOY;-- Total assets reached RMB311.52 billion, representing an increase of 2.7% as compared with that as of the end of last year;-- Return on average equity was 13.33%, representing an increase of 3.5 percentage points as compared with that for the same period of last year;-- Non-performing asset ratio was 0.78%, representing a decrease of 0.02 percentage point compared with that as at the end of last year;-- Continue to maintain high credit ratings, "A1" by Moody's, "A" by Standard & Poor's and "A+" by Fitch. In the first half of 2021, CDB Leasing maintained strategic determination, strengthened responsibility, adhered to ...

ACN Newswire

Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia

indie 26 8 月

4 minutes

ADELAIDE, AUS, Aug 26, 2021 - (ACN Newswire via SEAPRWire.com) - Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on "Non-clinical and clinical pathways for rapid vaccine development in Australia", in a webinar hosted by Endpoints News Editor Arsalan Arif.Agilex Biolabs' Director, Immunoassay, Kurt J. Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D, PGCM) said:"The COVID-19 pandemic has seen the rapid development of a series of novel vaccines targeting SARS-CoV-2. Development of multiple COVID-19 vaccine candidates has been facilitated within Australia by the availability of high-quality contract research organizations such as Agilex Biolabs, and a favorable regulatory environment. This webinar will cover the pathways that biotech companies can take for rapid vaccine development, and why Australia is the ideal location. I am joined by my toxicology expert colleagues Dr Peter Tapley and Dr Drew Brockman for this detailed vaccine development webinar."In this webinar Dr Sales and specialists from Agilex Biolabs' toxicology firm, TetraQ Toxicology will provide an overview of s...

ACN Newswire

Apollomics, Inc. Doses First Patient in Phase I Clinical Trial of APL-102

indie 10 8 月

2 minutes

Foster City, CA, Hangzhou and Shanghai, China, Aug 10, 2021 - (ACN Newswire via SEAPRWire.com) - Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination oncology therapies, today announced the successful dosing of the first patient in a Phase I clinical study of APL-102 in patients with advanced solid tumors. The Phase I trial is designed to assess the safety, tolerability and pharmacokinetics of APL-102 delivered via an oral capsule."APL-102 is an internally discovered and developed tyrosine kinase inhibitor targeting multiple oncogenic drivers, and we are excited about advancing it for clinical testing to explore its potential for treating a number of solid tumors;" said Guo-Liang Yu, PhD, Co-Founder, Chairman and Chief Executive Officer. "APL-102 is the first of several novel assets planned for clinical development to further expand Apollomics' clinical pipeline in oncology."About APL-102APL-102 is an oral, small molecule multi kinase inhibitor (MTKi) targeting several key oncogenic drivers. APL-102 inhibits several receptor tyrosine kinases (RTKs), including: angiogenesis via vascular endothelial growth factor...

ACN Newswire

Apollomics, Inc. Doses First Patient in A Phase I Clinical Trial of APL-102

indie 10 8 月

2 minutes

ACN Newswire

Dusit International makes its Oman debut with the opening of dusitD2 Naseem Resort, Jabal Akhdar

indie 6 7 月

5 minutes

Jabal Akhdar, Oman, Jul 6, 2021 - (ACN Newswire via SEAPRWire.com) - Dusit International, one of Thailand's leading hotel and property development companies, has expanded its presence in the Middle East with the opening of dusitD2 Naseem Resort, Jabal Akhdar - the first Dusit-branded hotel in Oman.dusitD2 Naseem Resort, Jabal Akhdar, OmanMs Suphajee Suthumpun, Group CEO, Dusit InternationalOwned by the Oman Tourism Development Company (OMRAN), which is the executive arm of the Sultanate for tourism development, the deluxe resort is located within a brand new 8,000 sq m Adventure Park on the Saiq Plateau in the Jabal Akhdar area, just a five-minute drive from the 'Grand Canyon of the Middle East,' and two hours by car from Muscat International Airport.Comprising 252 beautifully decorated rooms and suites, the contemporary resort fully embraces its unique mountain location with a spacious layout that blends seamlessly with its stunning natural surrounds.Alongside breathtaking views, guests can enjoy a wide range of facilities, including an all-day dining restaurant, a fitness centre, and a large outdoor swimming pool. A specialty restaurant, a Kids Club, and a signature Namm spa offe...

ACN Newswire

Alco Announces 2020/21 Annual Results, Notebook Computer Brand Business Thriving Amid Challenging Environment

indie 30 6 月

4 minutes

HONG KONG, Jun 30, 2021 - (ACN Newswire via SEAPRWire.com) - Alco Holdings Limited ("Alco" or the "Group"; stock code: 00328), a world-leading manufacturer of electronic products, announced its annual results for the year ended 31 March 2021 (the "Year").Year 2020 was challenging due to the COVID-19 pandemic, nonetheless, with notebook computers in strong demand, the Group recorded a 33% increase in turnover to HK$1,279 million (2020: HK$961 million). Notebook computer sales were HK$632 million, representing 261% year-on-year growth (2020: HK$175 million), with sales volume near a quarter million units, evidencing the popularity and consumer acceptance of Alco's notebook computer brands.During the Year, the Group's gross loss margin improved by 1.9 percentage points to -4.8% (2020: -6.7%), and net loss attributable to equity holders of the Company improved by 40% to HK$360 million (2020: HK$599 million). Certain sales orders were abandoned during the Year compelled by the global supply shortage of various electronic parts and components, and suppliers unable to timely deliver critical components, as such the Group's profitability was affected. Nevertheless, net loss attributable to...

ACN Newswire

SCCG Management Joins Forces with Paul Miller to Strengthen its Business Development Capabilities in Australia, APAC Countries

indie 28 6 月

2 minutes

LAS VEGAS, NV, Jun 28, 2021 - (ACN Newswire via SEAPRWire.com) - Stephen Crystal, Founder, SCCG Management, announced a partnership with Paul Miller, to build its business development capabilities in Australia and the Asia - Pacific Region.Paul Miller has 30 years of experience in senior management of tech companies in Australia and 11 years in the United States. He has assisted more than 100 tech companies in growing, entering new markets, acquiring new customers, and successfully led various M&A activities. He has advised gaming and tech companies in the US, Canada, UK, EU, LatAm, and Asia. His unique skill is to crystallize complex concepts into simple messages.Said Crystal on the event, "Paul is a rare talent in terms of being both an experienced tech executive and businessman with a strong history of entrepreneurial successes, globally. We are very excited to be able to build our business and market development talent through Paul's guidance and reach."About SCCG ManagementSCCG Management is a consultancy that specializes in sports betting, iGaming, sports marketing, affiliate marketing, technology, intellectual property protection, product commercialization, esports, capi...

ACN Newswire

Mengniu Releases 2020 Sustainability Report

indie 26 6 月

5 minutes

HONG KONG, Jun 26, 2021 - (ACN Newswire via SEAPRWire.com) - China Mengniu Dairy Company Limited ("Mengniu" or the "Group", HKEx: 2319), one of the leading dairy product manufacturers in China, announced that it has issued its 2020 Sustainability Report, which highlights Mengniu's practices and achievements in five key areas, including sustainability management, corporate governance, economy: more nutritious products, society: a better life, and environment: a more sustainable earth. In 2020, Mengniu adhered to its vision of "Promising a Healthier World" and its mission of "Producing More Nutritious Products, Guiding Consumers Towards a Better Life, and Safeguarding a Sustainable Planet", and reaffirms its commitment to sustainable development.Mr. Lu Minfang, Chief Executive Officer of Mengniu, commented, "Guided by a strong conviction that clear waters and green mountains are invaluable assets on our earth, we strongly believe that creating a path to sustainable development is the best choice for Mengniu's future. For the benefit of humanity and our planet, we continually imbed social responsibility into the foundation of our business, and sustainable development into the DNA of M...

SeaPRwire

Opportunities for public-private tie-ups in sustainable infrastructure development despite Covid-19: Indranee Rajah

aseanpr 23 6 月

3 minutes

SINGAPORE - Delivering quality and sustainable infrastructure has been made more challenging with the pandemic, and will be even more complex due to climate change and rapid urbanisation. But there are opportunities for partnerships and co-creation among governments, multilateral development banks and private sector, said Minister in the Prime Minister's Office Indranee Rajah. She was delivering a keynote address at the Asia Infrastructure Forum on Wednesday (June 23) at Marina Bay Sands Expo and Convention Centre. Held in a hybrid format this year due to Covid-19, the event, jointly organised by the Ministry of Finance, Enterprise Singapore, Monetary Authority of Singapore (MAS) and Infrastructure Asia, drew more than 2,000 participants. Ms Indranee, who is also Second Minister for Finance and National Development, said Covid-19 has led to an almost 4.5 per cent drop in global economic growth. In Asean last year, all countries experienced an average fiscal deficit of 7.6 per cent of gross domestic product. "Asian governments and multilateral development banks have identified infrastructure as an important means of achieving economic recovery through increased access to financial f...

JCN Newswire

Mazda Announces New Technology and Product Policy towards 2030 Based on Sustainable Zoom-Zoom 2030

ruth 17 6 月

4 minutes

TOKYO, Jun 17, 2021 - (JCN Newswire via SEAPRWire.com) - Mazda Motor Corporation today announced its new technology and product development policy towards 2030 based on the company's long-term vision for technology development, "Sustainable Zoom-Zoom 2030." Based on our revised Medium-Term Management Plan and our endeavor for carbon neutrality by 2050, which were announced in the past year, we will proceed with technology and product development towards 2030 following the below five policies.1. Accumulation of technological assets in line with our building block strategy and their utilization for highly efficient manufacturingMazda has consistently followed its Building Block Strategy to efficiently deliver superior technologies by building up a set of fundamental technologies as "blocks".This started with the development of "SKYACTIV Technology" in 2007 which updated our internal combustion engines. The basic electrification technologies were then added to compose our first building-block. Applicable to various products, this architecture became a technological asset to create our product group since 2012.We are continuously enhancing our internal combustion engines (SKYACTIV-X an...

JCN Newswire

Eisai Receives Special Prize at Platinum Career Award 2021

ruth 9 6 月

2 minutes

TOKYO, Jun 9, 2021 - (JCN Newswire via SEAPRWire.com) - Eisai Co., Ltd. announced today that it has received a special prize at the Platinum Career Award 2021. The awards ceremony was held via online at the symposium on June 8, 2021. The Platinum Career Award was established in 2019 with the aim of commending companies that aspire to provide opportunities for employees to develop their career and play an active role, in order to realize career paths that Japanese employees are aiming for in the era of the 100 years' life. (This event was held with sponsorship and planning by Mitsubishi Research Institute, Inc., planning by Mitsubishi UFJ Trust and Banking Corporation, support by the Ministry of Health, Labour and Welfare, Japan, and Tokyo Stock Exchange, Inc., and cooperation from TOYO KEIZAI INC.). Eisai received a special prize dedicated to companies that are implementing "new working styles initiated to adjust with the era of Corona (COVID-19 Pandemic)". Eisai defines our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," in the articles of incorporation, which we call our human health care (hhc) philos...

ACN Newswire

Apex-Brasil Introduce 10 Local Brazilian Start-ups to Participate in the Corporate Innovation Summit cum Global Matching 2021

indie 26 5 月

4 minutes

HONG KONG, May 26, 2021 - (ACN Newswire via SEAPRWire.com) - The Brazilian Trade and Investment Promotion Agency ("Apex-Brasil") committed to seek business opportunities for Brazilian products and services abroad, and to attract strategic foreign investment and impel the Brazilian economy. Apex Brasil is invited by Hong Kong Science and Technology Park Corporation ("HKSTP") to recommend ten local Brazilian start-ups participate in the the Corporate Innovation Summit cum Global Matching 2021 to strengthen communication between start-ups and multinational investors, as well as one-on-one matching meetings for corporate buyers to drive innovation adoption at speed and scale. Mr. Manuel Innocencio de Lacerda Santos Junior, the Consul-General of the Federative Republic of Brazil in Hong Kong will attend the event in person.The Corporate Innovation Summit cum Global Matching 2021 aims to provide a platform for start-ups and technology corporation to expand business networks and connect potential corporate buyers and investors. Programs including roundtables, roadshows, matching, VIP tour and luncheon, etc. Featured leading-edge sessions to gather the leaders, influence the leaders and le...

ACN Newswire

Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Administration

indie 24 5 月

4 minutes

HONG KONG, May 24, 2021 - (ACN Newswire via SEAPRWire.com) - Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company"; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, announced that on 13 May 2021, two pharmaceutical products of the Company, namely Bimatoprost Timolol eye drop (a potential first-to-market generic drug in China targeting glaucoma, a fixed dose combination of a prostaglandin analogue and a beta-blocker) and Epinastine HCl eye drop (a potential first-to-market generic drug in China targeting allergic conjunctivitis with a dual mechanism of action of anti-histamine and mast cell stabilization), passed the on-site inspection for drug registration of the Greater Bay Area Center for Drug Evaluation of NMPA. The inspection verified the original records and information on the research and development as well as the manufacturing processes of the above two drug products.The Company also passed the Good Manufacturing Practice (GMP) compliance inspection conducted by the Guangdong Medical Products Administration. It confirms that the Comp...

JCN Newswire

Eisai and National Cancer Center Commence Joint Research and Development Project

ruth 14 5 月

4 minutes

TOKYO, May 14, 2021 - (JCN Newswire via SEAPRWire.com) - Eisai Co., Ltd. and the National Cancer Center Japan announced today that both parties have entered into a joint research and development (R&D) agreement concerning "Basic research on the drug discovery and development to accelerate development of anticancer drugs in treatment of patients with rare cancers and refractory cancers", and that research activities have commenced. This R&D project is to be carried out with funding under the program "Cyclic Innovation for Clinical Empowerment (CiCLE)" established by the Japan Agency for Medical Research and Development (AMED). Rare cancer is a disease for which it is difficult for pharmaceutical companies to develop new drugs solo due to the extremely small number of patients, and there are only a limited number of drugs for rare cancers that can be approved for manufacturing and marketing. Also, among certain types of cancer with a large number of patients, refractory cancers, for which standard treatment has not been established, face barriers to creating new drugs due to difficulty of research and development. In order to promptly deliver effective treatments to patients ...

ACN Newswire

Fajarbaru upbeat on property segment’s outlook in Malaysia and Australia

indie 6 5 月

4 minutes

KUALA LUMPUR, May 6, 2021 - (ACN Newswire via SEAPRWire.com) - Fajarbaru Builder Group Bhd, a Bursa Malaysia Main Market listed company primarily involved in construction and property development, is upbeat on its property segment's outlook in anticipation of the economic recovery supported by the National Covid-19 Immunisation Programme. The company is also looking to launch new property projects towards second half of this year once market conditions improve.The Group recently completed its maiden development Rica Residence @ Sentul on schedule, and started handover in mid-March this year. The handover was originally due to kick off up to 3 months earlier, but was delayed due to MCO restrictions.Fajarbaru Group Chief Executive Officer Dato' Sri Eric Kuan Khian Leng said: "The property division remains a significant revenue generator for the Group in addition to our core business in construction. We have property development interest not just in Malaysia but in Australia as well. Although the Covid-19 pandemic has certainly affected the property segment, there are positive signs that market conditions will improve and we can capitalise on it as long as we adapt and innovate accord...

JCN Newswire

Hitachi and Axcelead have agreed to start joint development of solutions contributing on more efficient creation of next-generation biopharmaceuticals

ruth 7 4 月

4 minutes

TOKYO, Apr 7, 2021 - (JCN Newswire via SEAPRWire.com) - Hitachi, Ltd. (TSE:6501) and Axcelead, Inc. today announced that they have agreed on a comprehensive collaborative partnership to develop solutions contributing on more efficient creation of next-generation biopharmaceuticals with digital technology and drug discovery platform. Hitachi has also made investment to Drug Discovery Gateway Fund ("DDG Fund") managed by Whiz Partners Inc. (President: Atsushi Matsumura, "Whiz"). Axcelead is the flagship portfolio company of DDG Fund.With continuous progress of life science, practical applications of next-generation biopharmaceuticals with new therapeutics modalities(1) demonstrating better balance of efficacy and side-effect, such as genes-, cell-, and mRNA(2)- therapeutics, have been recognized. Those new drug discovery modalities are also contributing to the speedy and variety development of vaccines and therapeutics for COVID-19.On the other hand, next-generation biopharmaceuticals are more expensive to develop and manufacture than low-molecular-weight pharmaceuticals, and due to their nature, the product stability and effective period and product life are shorter, and it would be...

ACN Newswire

保德国际公布有关认购千洋投资有限公司65%股权之非常重大收购事项

tallulah 30 3 月

1 minute

HONG KONG, Mar 30, 2021 - (亚太商讯 via SEAPRWire.com) - 保德国际发展企业有限公司（「保德国际」或「公司」，联同其附属公司统称为「集团」；港交所股票代号：372）公布有关认购千洋投资有限公司65%股权之非常重大收购事项。保德国际于2021年3月29日通过公司之全资附属公司PT OBOR Financial Holdings Limited（「PT OBOR」）与千洋投资有限公司（「千洋投资」）及担保人订立认购协议，以按认购价（即赎回金额，为优先股之认购价200,000,000港元与直至完成日期止之应计金额（直至二零二一年三月三十一日止之应计金额约为3,825,000港元，仅供参考）之总和）认购668,571,429股千洋投资之新普通股。根据认购价，每股认购股份之价格须为约0.3049港元。认购价将于完成时透过抵销千洋投资为赎回千洋投资于二零一八年四月十六日向PT OBOR发行之优先股应付之赎回金额支付。于完成后，PT OBOR将持有千洋投资经认购股份扩大后之全部已发行股份约65.0%，而千洋投资发行之所有优先股须已获悉数赎回。千洋投资为一间于香港注册成立之有限公司，其全部投票权于完成前由担保人全资实益拥有。千洋投资持有其中国附属公司广西广明码头仓储有限公司（「广西广明」）75%股权，余下25%股权由上海鉴宸实业发展有限公司（由京港联兴（北京）国际贸易发展有限公司（「京港联兴」）全资拥有）持有。广西广明成立于一九九五年，主要业务为提供石化港口及仓储服务以及港口相关服务。其主要透过于中国广西省钦州港金谷区鹰岭岭作业区（「钦州港」）经营码头（「码头」）从事处理及储存液体危险品（如汽油、柴油、混合芳烃及燃油）业务。该公司持有经管码头所需之牌照及许可证，包括港口经营许可证及港口危险货物作业附证。钦州港为邻近南亚国际航运中心广西钦州石油化工园区（「钦州石油化工园区」）中最繁忙的深水港口，而钦州石油化工园区为华南其中顶级的石油化工园区。集团相信，是次认购事项为本集团带来宝贵的机遇，令本集团得以扩大中游资产组合，并在中国的战略位置拥有港口和仓储设施。管理层认为，投资港口相关业务将为中国经济增长的重要部分，石油化工行业亦将较傅统货运码头产生更佳回报。因此，本集团决定策略地于商品买卖供应链上移至中游投资于仓储设施（大型商品贸易公司通常拥有的中游资产）。广西广明是广西唯一以中外合资企业形式拥有石油化工码头及仓储设施之实体。是次认购事项及于Yangtze Prosperity Development Limited及STX Corp之投资，本集团将成为亚洲综合商品贸易公司业务之一部分。千洋投资、Yangtze Prosperity Development Limited及STX Corp之资产及资源使集团向其商品贸易业务之供货商及客户...

ACN Newswire

Greenland Hong Kong’s Core Business Continues Performing Well in 2020, Leads High-quality Development with ‘Two Wings in One’ Strategy

indie 26 3 月

9 minutes

HONG KONG, Mar 26, 2021 - (ACN Newswire via SEAPRWire.com) - Greenland Hong Kong Holdings Limited ("Greenland Hong Kong", HKG: 00337) held an online 2020 annual results conference in Shanghai, Mr. Chen Jun (Chairman and Chief Executive Officer of Greenland Hong Kong), Mr. Chen Zeng Li (Vice President) and Mr. Lei Yu (Secretary of the Board) attending the press conference. Business Highlights (as of 31 December, 2020):-- Revenue was approximately RMB33.73 billion -- Total Assets was approximately RMB164.99 billion -- Net Profit were approximately RMB3,459 million-- Profit for the year attribute to the owners of the Company was approximately RMB2,608 million-- Gross Profit was approximately RMB8,249 million. Gross Profit Margin reached 24.5%.-- Earnings per share amounted to RMB0.94 per share -- Contracted Sales reached approximately RMB54.53 billion, increase 13% year-on-year-- The Board of Directors have recommended the payment of a final dividend of HK$[-] per Ordinary Share for the year ended 31 December 2020 -- As at the date of the annual results announcement, Greenland Hong Kong has added approximately 12.15 million square meters of gross floor area (GFA) that costed 149.6 bil...

JCN Newswire

Mitsubishi Corporation Enters Agreement to Acquire Interest in Aurukun Bauxite Project

ruth 18 3 月

2 minutes

TOKYO, Mar 18, 2021 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Corporation (MC) is pleased to announce it has reached an agreement with Glencore Plc (Glencore, head office located in Switzerland) to acquire a 30% interest in the Aurukun Bauxite Project in Australia currently wholly owned by Glencore.In addition to MC's existing aluminum smelting and trading operations, this acquisition marks MCʼs first investment in the mining of bauxite, a raw material of aluminum.MC's mineral resources group conducts business through investment and development of resources such as iron ore and aluminum, in addition to its core operations in metallurgical coal and copper, aspiring to improve global outcomes by contributing to the transition to a low-carbon/decarbonized society, and to create new values through digital transformation (DX). With its unique lightweight properties and ability to be endlessly recycled, aluminum plays an important role in reducing greenhouse gas emissions, of which a particular case is when it is used to manufacture electrical vehicles where the lightness of material is integral. As the metal commonly used in construction such as sashes, walls, and roofing...

ACN Newswire

Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer

indie 9 3 月

4 minutes

Foster City, CA, and Hangzhou, China, Mar 9, 2021 - (ACN Newswire via SEAPRWire.com) - Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced the appointment of K. Peony Yu, M.D. as Chief Medical Officer. Dr. Yu will assume the role on March 16, 2021. Apollomics also announced that Sophie (Zhengjie) Sun has been named as Senior Vice President, Corporate Development and will be based in the Company's China office. Both executives report to Guo-Liang Yu, PhD, Co-Founder, Chairman and Chief Executive Officer of the Company."Dr. Yu joins us with an incredible leadership and global drug development background that is a perfect fit for Apollomics, and we are thrilled to welcome her to our team," said Guo-Liang Yu, PhD, Co-Founder, Chairman and Chief Executive Officer. "Peony's extensive cross border experience includes managing teams in both the U.S. and China and overseeing multiple functions including clinical development, regulatory strategy and medical affairs. Peony will be instrumental in our efforts to advance our current assets and expand our development pipeline." "Apollom...

2026 年 4 月
一	二	三	四	五	六	日
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30